Sign in or Register   Sign in or Register
  |  

Mouse Anti-LIAS Recombinant Antibody (CBYCL-309) (CBMAB-L0210-YC)

Provided herein is a Mouse monoclonal antibody against Human LIAS. The antibody can be used for immunoassay techniques, such as WB.
See all LIAS antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBYCL-309
Antibody Isotype
IgG2a
Application
WB

Basic Information

Specificity
Human
Antibody Isotype
IgG2a
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
lipoic acid synthetase
Introduction
LIAS belongs to the biotin and lipoic acid synthetases family. It localizes in mitochondrion and plays an important role in alpha-(+)-lipoic acid synthesis. It may also function in the sulfur insertion chemistry in lipoate biosynthesis. Diseases associated with LIAS include Hyperglycinemia, Lactic Acidosis, And Seizures and Lipoic Acid Synthetase Deficiency.
Entrez Gene ID
UniProt ID
Alternative Names
HGCLAS; HUSSY-01; LAS; LIP1; LS; PDHLD
Function
Catalyzes the radical-mediated insertion of two sulfur atoms into the C-6 and C-8 positions of the octanoyl moiety bound to the lipoyl domains of lipoate-dependent enzymes, thereby converting the octanoylated domains into lipoylated derivatives.
Biological Process
Inflammatory responseISS:UniProtKB
Lipoate biosynthetic processISS:UniProtKB
Neural tube closureIEA:Ensembl
Protein lipoylationIEA:UniProtKB-UniRule
Response to lipopolysaccharideISS:UniProtKB
Response to oxidative stressISS:UniProtKB
Cellular Location
Mitochondrion
Involvement in disease
Hyperglycinemia, lactic acidosis, and seizures (HGCLAS):
An enzymatic defect resulting in an autosomal recessive disorder of mitochondrial metabolism. It is characterized by early-onset lactic acidosis, severe encephalomyopathy, and a pyruvate oxidation defect. Affected individuals have neonatal-onset epilepsy, poor growth, psychomotor retardation, muscular hypotonia, lactic acidosis, and elevated glycine concentration in plasma and urine.
Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-LIAS Recombinant Antibody (CBYCL-309)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare